Fasching, P. A., Hack, C. C., Nabieva, N., Maass, N., Aktaş, B., Kümmel, S., . . . Sütterlin, M. (2024). Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole. European journal of cancer, 209, . https://doi.org/10.1016/j.ejca.2024.114239
Chicago-Zitierstil (17. Ausg.)Fasching, Peter Andreas, et al. "Prognostic Impact of Selection Criteria of Current Adjuvant Endocrine Therapy Trials NATALEE and MonarchE in Postmenopausal HRpos/HER2neg Breast Cancer Patients Treated with Upfront Letrozole." European Journal of Cancer 209 (2024). https://doi.org/10.1016/j.ejca.2024.114239.
MLA-Zitierstil (9. Ausg.)Fasching, Peter Andreas, et al. "Prognostic Impact of Selection Criteria of Current Adjuvant Endocrine Therapy Trials NATALEE and MonarchE in Postmenopausal HRpos/HER2neg Breast Cancer Patients Treated with Upfront Letrozole." European Journal of Cancer, vol. 209, 2024, https://doi.org/10.1016/j.ejca.2024.114239.